Seattle Institute for Biomedical and Clinical Research
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Seattle Institute for Biomedical and Clinical Research sits in the top decile of US sponsors by registered trial count (#415 of 15,742 sponsors by registered trial count).
Seattle Institute for Biomedical and Clinical Research: 43 sponsored US clinical trials, 6 recruiting.
Seattle Institute for Biomedical and Clinical Research sponsors 43 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 29 completed. 5 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypogonadism, Male, with 2 trials.
Top-decile sponsor footprint
Seattle Institute for Biomedical and Clinical Research ranks in the top decile of sponsors by registered trial count (#415 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
29 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
43 total, page 1 of 1
Automatic Prosthetic Foot Stiffness Modulation to Improve Balance
NCT06711588
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
NCT06390345
A Prosthetic Foot Test-Drive Strategy for Improving Stability in Veterans With Leg Amputations
NCT05473065
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
NCT05718102
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
NCT04049331
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
NCT04301765
Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma
NCT05776719
Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
NCT04505371
Comparing Ankle Fusion to Ankle Replacement
NCT01620541
Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults
NCT07507435
High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults
NCT03856879
Adherence and Perspiration While Wearing Lower Limb Prostheses
NCT03900845
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
NCT03867357
A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations
NCT03651830
Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population
NCT03468309
INtervention Study In overweiGHT Patients With COPD
NCT02634268
Prazosin for Post-Concussive Headaches
NCT02965027
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
NCT02985021
Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
NCT02322047
Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
NCT02226367
Effect of Dietary Glycemic Index on Beta-cell Function
NCT01386645
Mindfulness-Based Stress Reduction and the Microbiome
NCT01619384
Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
NCT01126099
Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)
NCT01607632
Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder
NCT01518972
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
NCT00990106
Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance
NCT00760994
Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study
NCT00880152
Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data
NCT00880256
Quetiapine for the Reduction of Cocaine Use
NCT00631748
Study of the Medication Prazosin for Alcohol Dependence
NCT00762710
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
NCT00512070
A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
NCT00284206
Efficacy of Galantamine to Treat Schizophrenia
NCT00232349
Cognitive Effects of Aerobic Exercise for MCI Adults
NCT00220467
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
NCT00202514
Cognitive Effects of Aerobic Exercise for IGT Adults
NCT00220441
Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance
NCT00202449
Quetiapine for Cocaine Use and Cravings
NCT00232336
Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
NCT00183430
The Effect of H. Pylori Infection on Iron Metabolism
NCT00202488
Do HMG CoA Reductase Inhibitors Affect Abeta Levels?
NCT00303277
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
NCT00007189
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 11 |
| Phase 3 | 1 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Seattle Institute for Biomedical and Clinical Research pipeline
6 recruiting of 43 indexed (14% open); 29 completed (67%).
Phase mix: 5 late (III/IV) vs 11 early (I/II) (early-phase heavy).
Top condition: Hypogonadism, Male (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Seattle Institute for Biomedical and Clinical Research: open-pipeline peers nationwide
Peers matched on 43 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Seattle Institute for Biomedical and Clinical Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 43 trials (± recruiting share)
- Atlantic Health System · 43 trials · 16% recruiting
- Cumberland Pharmaceuticals · 43 trials · 2% recruiting
- Lahey Clinic · 43 trials · 9% recruiting
- Octapharma · 43 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- University of Illinois at Urbana-Champaign · 14% recruiting · 129 trials
- University of Pennsylvania · 14% recruiting · 1,423 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
Related
What to do with this Seattle Institute for Biomedical and Clinical Research page
43 registered trials is a research-attention snapshot, not an endorsement of Seattle Institute for Biomedical and Clinical Research or any single study.
- 6 of Seattle Institute for Biomedical and Clinical Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypogonadism, Male is the condition Seattle Institute for Biomedical and Clinical Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypogonadism, Male trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Seattle Institute for Biomedical and Clinical Research pipeline card: 43 registered trials from official public datasets.Report a data error.